AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
Log in

NYSE:USPHU.S. Physical Therapy Stock Price, Forecast & News

$74.14
-1.58 (-2.09 %)
(As of 06/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$73.24
Now: $74.14
$75.16
50-Day Range
$66.46
MA: $71.14
$77.74
52-Week Range
$45.13
Now: $74.14
$148.48
Volume137,400 shs
Average Volume141,911 shs
Market Capitalization$952.25 million
P/E Ratio32.81
Dividend Yield1.73%
Beta1.25
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors As of March 14, 2019, it operated 592 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.
Read More
U.S. Physical Therapy logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 2.0Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.44 out of 5 stars


Industry, Sector and Symbol

Industry Health services
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP90337L10
Phone713-297-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$481.97 million
Cash Flow$3.61 per share
Book Value$18.92 per share

Profitability

Net Income$40.04 million

Miscellaneous

Employees5,400
Market Cap$952.25 million
Next Earnings Date8/13/2020 (Estimated)
OptionableOptionable

Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.

U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

How has U.S. Physical Therapy's stock been impacted by COVID-19 (Coronavirus)?

U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, USPH shares have decreased by 20.5% and is now trading at $74.14. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of U.S. Physical Therapy?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for U.S. Physical Therapy.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for U.S. Physical Therapy.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) posted its quarterly earnings results on Thursday, May, 21st. The company reported $0.30 EPS for the quarter, missing the consensus estimate of $0.37 by $0.07. The business had revenue of $112.70 million for the quarter, compared to analyst estimates of $101.89 million. U.S. Physical Therapy had a return on equity of 13.48% and a net margin of 6.17%. The firm's revenue was down 3.0% on a year-over-year basis. During the same quarter last year, the company earned $0.66 earnings per share. View U.S. Physical Therapy's earnings history.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy announced a quarterly dividend on Friday, February 28th. Investors of record on Friday, March 13th will be given a dividend of $0.32 per share on Friday, April 17th. This represents a $1.28 annualized dividend and a yield of 1.73%. The ex-dividend date is Thursday, March 12th. This is an increase from U.S. Physical Therapy's previous quarterly dividend of $0.30. View U.S. Physical Therapy's dividend history.

What price target have analysts set for USPH?

3 equities research analysts have issued 1 year price targets for U.S. Physical Therapy's stock. Their forecasts range from $80.00 to $120.00. On average, they anticipate U.S. Physical Therapy's stock price to reach $100.00 in the next twelve months. This suggests a possible upside of 34.9% from the stock's current price. View analysts' price targets for U.S. Physical Therapy.

Has U.S. Physical Therapy been receiving favorable news coverage?

Headlines about USPH stock have trended very positive recently, according to InfoTrie. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. U.S. Physical Therapy earned a media sentiment score of 3.5 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutU.S. Physical Therapy.

Are investors shorting U.S. Physical Therapy?

U.S. Physical Therapy saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 1,110,000 shares, an increase of 7.8% from the April 30th total of 1,030,000 shares. Based on an average daily trading volume, of 165,300 shares, the days-to-cover ratio is presently 6.7 days. Currently, 8.8% of the company's stock are short sold. View U.S. Physical Therapy's Current Options Chain.

Who are some of U.S. Physical Therapy's key competitors?

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), Marathon Petroleum (MPC), Royal Caribbean Cruises (RCL), Starbucks (SBUX), AbbVie (ABBV), Carnival (CCL), Gilead Sciences (GILD), IBM (IBM), Lowe's Companies (LOW) and AT&T (T).

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the following people:
  • Mr. Christopher J. Reading, Pres, CEO & Director (Age 55)
  • Mr. Lawrance W. McAfee, Exec. VP, CFO & Director (Age 64)
  • Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 62)
  • Mr. Graham Reeve M.B.A., P.T., Chief Operating Officer of East (Age 55)
  • Mr. Jon C. Bates, VP & Corp. Controller

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (17.26%), Fred Alger Management LLC (4.10%), State Street Corp (3.39%), Riverbridge Partners LLC (2.90%), Copeland Capital Management LLC (2.31%) and Wasatch Advisors Inc. (2.26%). Company insiders that own U.S. Physical Therapy stock include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Jerald L Pullins, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson. View institutional ownership trends for U.S. Physical Therapy.

Which major investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including Blair William & Co. IL, Invesco Ltd., First Trust Advisors LP, WINTON GROUP Ltd, UBS Group AG, Schroder Investment Management Group, KBC Group NV, and Russell Investments Group Ltd.. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Lawrance W Mcafee, and Mark J Brookner. View insider buying and selling activity for U.S. Physical Therapy.

Which major investors are buying U.S. Physical Therapy stock?

USPH stock was bought by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Fred Alger Management LLC, Copeland Capital Management LLC, Morgan Stanley, Morgan Stanley, Bahl & Gaynor Inc., JPMorgan Chase & Co., and BlackRock Inc.. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin, and Regg E Swanson. View insider buying and selling activity for U.S. Physical Therapy.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $74.14.

How big of a company is U.S. Physical Therapy?

U.S. Physical Therapy has a market capitalization of $952.25 million and generates $481.97 million in revenue each year. The company earns $40.04 million in net income (profit) each year or $2.82 on an earnings per share basis. U.S. Physical Therapy employs 5,400 workers across the globe.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is www.usph.com.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]

This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.